Alpha DNA Investment Management’s Alcoa AA Stock Holding History

Alpha DNA Investment Management’s Portfolio AA Stock Details AA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-99	Closed	-$3K	–	101
2021 Q1	$3K	Buy	+99	New	+$2.5K	﹤0.01%	441

Other funds holding AA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Alpha DNA Investment Management's AA Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Alcoa (AA) in Q2 2021, closing a stake of 99 shares — an estimated $3K sold.

Alpha DNA Investment Management first reported a position in AA in Q1 2021 and held it in 1 quarter. The position peaked at $3K in Q1 2021. 419 funds tracked by Wall St. Rank hold AA as of Q2 2021.

Alpha DNA Investment Management reported no remaining Alcoa position as of Q2 2021 after selling out during the quarter.
Alpha DNA Investment Management sold 99 Alcoa shares in Q2 2021, an estimated $3K.
Alpha DNA Investment Management first reported a position in Alcoa in Q1 2021 and held it in 1 quarter.
Alpha DNA Investment Management's Alcoa position peaked at $3K in Q1 2021.
419 funds tracked by Wall St. Rank held Alcoa as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.